The discounts ranged from 38% for Austedo, which treats Huntington's disease, to 85% for Janumet for Type 2 diabetes
Both patients and doctors need to understand that these drugs also lower cardiovascular disease outcomes that may be even more important than their weight loss effects since cardiovascular disease is the leading cause of death for persons with diabetes or overweight/obesity (evidence already published for Ozempic showing reduction in cardiovascular events, pending for Wegovy and clinical trials are ongoing for Mounjaro). Type 2 diabetes can be managed
Methionine There are no randomized, controlled trials studying the effect of Lipo-MIC injections on pregnant women or their offspring
With careful management, wellness and hormone services can run 50-70% margins, but you have to know your supply costs
Most papers investigated correlations of plasma ghrelin levels in the fasted, or fed state, and less papers investigated the change in ghrelin levels following a meal (e.g., Sun et al., 2014)
Recent progress in sepsis epidemiology--have we learned enough
